Consideration of the effect of Artemisia absinthium on eye darkness
Phase 3
- Conditions
- Eye darkness.
- Registration Number
- IRCT20190413043259N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Suffering from eye darkness
Interesting to participate in this study
Age 18-65 both sexes
Suffering from eye darkness more than 6 month
Exclusion Criteria
Lactation
pregnancy
Use of solarium or sunbathing and sunburn 3 months prior to the study
History of laser treatment or dermabrasion or deep facial peels within the past 3 months
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction of darkness after using the medication. Timepoint: At the first- 2 weeks-4 weeks- 8 weeks. Method of measurement: Examination by physician- Test by Mexameter divice.
- Secondary Outcome Measures
Name Time Method